The Matrix – 50 Things You (and your customers) ought to know about the...
21. Enhanced Services: The GPs should have got copies of their enhanced services, particularly DES & NES. These are vital (cost £5 per copy)...
Pharma Industry – pricing crisis looms in 2004
Another crisis on pricing is looming over the European pharmaceutical industry in 2004, according to industry commentators at KPMG. STEPHEN OXLEY, Head of Pharmaceuticals,...
Are you suffering from CV phobia?
In over 5 years of recruiting sales professionals and having read and reviewed literally hundreds of CVs, I am constantly amazed at the poor...
Parallel trade strikes at industry’s ability to invest in search for new medicines
Parallel trade in medicines is threatening the ability of the research-based industry in the UK to continue its huge investment in the search for...
Benign Prostatic Hyperplasia
AN ENLARGED PROSTATE – known as benign prostatic hyperplasia or BPH – is caused by an overgrowth of prostate cells. This enlargement constricts the...
Erectile Dysfunction – Is Three a Crowd?
ince its launch in March 1998 Viagra has revolutionised the erectile dysfunction (ED) market. A blockbuster drug since its inception, the blue diamond-shaped pill...
French Connection
AFTER SEVERAL WEEKS of merger speculation, Sanofi-Synthelabo launched a hostile bid for French neighbours Aventis on 26th January 2004. The stock and cash deal...
THE RESOLUTION OF CONFLICT BY MUTUAL COMPROMISE
The 10 Rules of Negotiation by Alan McCarthy Associate Consultant, Catalyst In today’s increasingly competitive sales environment, an...
Surviving in the Jungle
By Clare Willis, Senior Training Consultant, Speak First THE ABILITY TO DEVELOP GOOD WORKING relationships with a wide variety of people is a key...
The Matrix
This double special edition of the MATRIX provides a simple checklist of facts about the new GP contract. Given that this is time for...
Latest articles
NICE to work with GW Pharma on cannabidiol evaluation
NICE has announced its intention to work with GW Pharma to address the issues highlighted by its independent appraisal committee in its evaluation of...
NHS Spine marks five-year anniversary
NHS Spine is marking five years since it was brought in house by NHS Digital and run as an open source service for the...
Cyber threats in healthcare: What are the risks?
FireEye have released a new report detailing cyber threats facing the healthcare industry. The report focuses on the three types of threat most common in...
Popular articles
Positive phase III study results for injectable HIV-treatment regimen
ViiV Healthcare has announced positive headline results from its global phase III ATLAS-2M study of the investigational, long-acting, injectable, 2-drug regimen (2DR) of ViiV...
Gedeon Richter’s biosimilar for osteoporosis available on NHS
Gedeon Richter has announced that its biosimilar for osteoporosis, Terrosa® (teriparatide), is available on the NHS for the treatment of osteoporosis in postmenopausal women...
Cyber threats in healthcare: What are the risks?
FireEye have released a new report detailing cyber threats facing the healthcare industry. The report focuses on the three types of threat most common in...
NHS England makes Roche’s Hemlibra® available on NHS
NHS England has made Roche's Hemlibra® available on NHS. It is to fund the “life-changing treatment” for thousands of people with severe Haemophilia, which...
NICE to work with GW Pharma on cannabidiol evaluation
NICE has announced its intention to work with GW Pharma to address the issues highlighted by its independent appraisal committee in its evaluation of...